Jacques F. Meis, Consultant
Jacques F. Meis, Consultant
Centre of Expertise in Mycology Nijmegen NL, Federal University Parana, Curitiba, Brazil
Email verificata su cwz.nl
Titolo
Citata da
Citata da
Anno
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus
S Ascioglu, JH Rex, B De Pauw, JE Bennett, J Bille, F Crokaert, ...
Проблемы медицинской микологии 5 (1), 2003
2903*2003
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
SR Lockhart, KA Etienne, S Vallabhaneni, J Farooqi, A Chowdhary, ...
Clinical Infectious Diseases 64 (2), 134-140, 2017
5492017
Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria
R Agarwal, A Chakrabarti, A Shah, D Gupta, JF Meis, R Guleria, R Moss, ...
Clinical & Experimental Allergy 43 (8), 850-873, 2013
526*2013
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
A Skiada, L Pagano, A Groll, S Zimmerli, B Dupont, K Lagrou, C Lass-Florl, ...
Clinical Microbiology and Infection 17 (12), 1859-1867, 2011
4492011
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013
OA Cornely, S Arikan‐Akdagli, E Dannaoui, AH Groll, K Lagrou, ...
Clinical Microbiology and Infection 20, 5-26, 2014
4432014
A primer on cytokines: sources, receptors, effects, and inducers.
JH Curfs, JF Meis, JA Hoogkamp-Korstanje
Clinical microbiology reviews 10 (4), 742-780, 1997
4201997
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
AJ Ullmann, JM Aguado, S Arikan-Akdagli, DW Denning, AH Groll, ...
Clinical Microbiology and Infection 24, e1-e38, 2018
3872018
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections
MC Arendrup, T Boekhout, M Akova, JF Meis, OA Cornely, O Lortholary, ...
Clinical Microbiology and Infection 20, 76-98, 2014
376*2014
Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to…
MA Pfaller, DJ Diekema, DL Gibbs, VA Newell, JF Meis, IM Gould, W Fu, ...
Journal of clinical microbiology 45 (6), 1735-1745, 2007
365*2007
First hospital outbreak of the globally emerging Candida auris in a European hospital
S Schelenz, F Hagen, JL Rhodes, A Abdolrasouli, A Chowdhary, A Hall, ...
Antimicrobial Resistance & Infection Control 5 (1), 35, 2016
3512016
Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?
PE Verweij, A Chowdhary, WJG Melchers, JF Meis
Clinical Infectious Diseases 62 (3), 362-368, 2016
3512016
In vitro susceptibilities of zygomycetes to conventional and new antifungals
E Dannaoui, J Meletiadis, JW Mouton, JFGM Meis, PE Verweij
Journal of Antimicrobial Chemotherapy 51 (1), 45-52, 2003
3112003
Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally
A Chowdhary, C Sharma, JF Meis
PLoS pathogens 13 (5), e1006290, 2017
3082017
Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization–time of flight mass spectrometry and DNA…
S Kathuria, PK Singh, C Sharma, A Prakash, A Masih, A Kumar, JF Meis, ...
Journal of clinical microbiology 53 (6), 1823-1830, 2015
2962015
Nosocomial fungal infections: candidemia
FMV Lunel, JFGM Meis, A Voss
Diagnostic microbiology and infectious disease 34 (3), 213-220, 1999
2761999
An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis
M Ellis, D Spence, B Pauw, F Meunier, A Marinus, L Collette, R Sylvester, ...
Clinical infectious diseases 27 (6), 1406-1412, 1998
2761998
Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan.
CM Swanink, JF Meis, AJ Rijs, JP Donnelly, PE Verweij
Journal of Clinical Microbiology 35 (1), 257-260, 1997
2691997
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others
AM Tortorano, M Richardson, E Roilides, A Van Diepeningen, M Caira, ...
Clinical Microbiology and Infection 20, 27-46, 2014
2632014
Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients.
PE Verweij, D Stynen, AJ Rijs, BE De Pauw, JA Hoogkamp-Korstanje, ...
Journal of Clinical Microbiology 33 (7), 1912-1914, 1995
2621995
In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates
J Meletiadis, JW Mouton, JFGM Meis, PE Verweij
Antimicrobial Agents and Chemotherapy 47 (1), 106-117, 2003
2602003
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20